key: cord-0788063-63apxcw6
authors: Zhang, Qingpeng
title: Benefits of COVID-19 non-pharmaceutical interventions on the prevention of other notifiable infectious diseases
date: 2021-10-21
journal: Lancet Reg Health West Pac
DOI: 10.1016/j.lanwpc.2021.100303
sha: 1cc069dd157f3313398352117754b00f4a9cc7f0
doc_id: 788063
cord_uid: 63apxcw6

nan

COVID-19-targeted non-pharmaceutical interventions (NPIs) have been demonstrated to be effective in containing the pandemic [1] , while they often come at the expense of harmful effects on the health and economy because of the interrupted and delayed health care, increased risk of mental diseases and domestic violence, and elevated unemployment, inequity, poverty, and social disruptions [2] . These negative effects have led to the relaxation of NPIs in several well-vaccinated countries, such as U.K. and U.S., even with rising COVID-19 cases.

However, the population-wide COVID-19 vaccination program is only available in a few developed countries [3] . The latest research showed that several viral mutations in SARS-Cov-2 can escape antibody binding and reduce the efficacy of vaccines [4] . As a result, NPIs will still be inevitable in many countries, particularly lowand middle-income countries [5] . It is therefore important to examine not only the negative effects, but also the positive effects of COVID-19-targeted NPIs in addition to the pandemic control. Recent studies have shown that several infectious diseases, such as influenza, were suppressed during the pandemic [ 2 , 6 , 7 ] . However, there is a lack of detailed characterisation of demographics and the spatiotemporal scales in a large population, which could be heterogeneous in benefiting from NPIs.

In this issue of The Lancet Regional Health -Western Pacific , Jianpeng Xiao and colleagues present findings on the co-benefits of COVID-19-targeted NPIs on notifiable infectious diseases (NIDs) in Guangdong, a province with 126 million population in China [8] . The authors harnessed the NIDs data from the Notifiable Infectious Diseases Surveillance System, an internet-based reporting system developed by the China Center for Disease Control and Prevention, and the demographic data from Guangdong Statistics Yearbook. China has undergone one of the most stringent NPIs, which are a combination of mass testing, intensive surveillance, domestic and international travel restrictions, border control, quarantine, manual and digital contact tracing, school closure, mandatory maskwearing, and repeated lockdowns [1] . The authors compared the incidence of NIDs during the emergency response period in 2020 with that in the same period of 2015-2019, as well as with the expected incidence as predicted by a Bayesian structural time series model. Results showed that the stringent NPIs deployed in Guangdong had significant co-benefits in reducing the incidence of NIDs with demographic, spatiotemporal and disease-specific heterogeneity. The reduction in NIDs was the largest in natural focal diseases and insect-borne infectious diseases (89 • 4%), followed by respiratory infectious diseases (87 • 4%) and intestinal infectious diseases (59 • 4%). The reduction in blood-borne and sexually transmitted infections was smaller (18 • 2%), but still noticeably higher than that in other countries. Children and the residents in more economically developed cities were found to benefit from NPIs more than other populations.

Xiao et al. [8] make unique additions to the growing evidence that COVID-19-targeted NPIs can prevent other NIDs from the unique perspective of NPIs' heterogeneous demographic, spatiotemporal and disease-specific effects on a large population of 126 million, indicating that certain groups of people may benefit more from COVID-19-targeted NPIs. Such a more detailed understanding of NPIs' benefits has the potential to inform public health policies on the prevention of NIDs during and after the pandemic. In the future, when COVID-19 or similar infectious disease-targeted NPIs are being deployed, clinicians and public health professionals will be equipped with the data-driven insights to make better resource allocation in anticipation, rather than in response to the upcoming demand of health care resources. The findings also set a benchmark for evaluating the effectiveness of various NPIs in preventing NIDs.

Several important questions remain unanswered in [8] . lems in the NIDs data, because of people's hesitation to visit the hospital and limited health care resources during the pandemic. Second, the susceptible population for other NIDs increased while COVID-19-targeted NPIs were in place, and thus might pose a greater risk of future outbreaks of NIDs following NPIs [9] . Decision-makers and public health professionals should consider not only the reduced incidence but also the heavier burden on healthcare systems because of the increased susceptible population while lifting up NPIs and reopening borders. Third, social and economic factors were not considered in this study. How to balance the benefits of NPIs and the cost of economy is a new question that yet to be answered. Fourth, the results should be further validated by a prospective longitudinal study. Fifth, domestic, inter-provincial and international human mobility data could have been better incorporated in such observational study, so that the effect of individual measures, such as travel restrictions, can be better characterized. To answer these questions, scientists in all disciplines should join forces in identifying novel data and developing advanced data science techniques to integrate and analyse the multi-source and multi-aspect data [10] .

The authors declare no conflict of interest.

Effect of non-pharmaceutical interventions to contain COVID-19 in China

Effects of non-pharmaceutical interventions against COVID-19 on the incidence of other diseases. The Lancet Regional Health-Europe

The impact of COVID-19 and strategies for mitigation and suppression in low-and middle-income countries

Covid-19 vaccine against the B. 1.351 variant

Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period

Seasonal influenza activity during the SARS-CoV-2 outbreak in Japan

Impact of COVID-19 outbreaks and interventions on influenza in China and the United States

Co-benefits of nonpharmaceutical intervention against COVID-19 on infectious diseases in China: A large population-based observational study. The Lancet Regional Health-Western Pacific

The impact of COVID-19 nonpharmaceutical interventions on the future dynamics of endemic infections

Data Science Approaches to Confronting the COVID-19 Pandemic: A Narrative Review